Endymed Past Earnings Performance
Past criteria checks 0/6
Endymed's earnings have been declining at an average annual rate of -24.5%, while the Medical Equipment industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 7.3% per year.
Key information
-24.5%
Earnings growth rate
-24.5%
EPS growth rate
| Medical Equipment Industry Growth | 15.2% |
| Revenue growth rate | 7.3% |
| Return on equity | -13.7% |
| Net Margin | -9.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Endymed Ltd's (TLV:ENDY) Share Price Boosted 43% But Its Business Prospects Need A Lift Too
Nov 07
Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues
Sep 23Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected
Aug 06Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital
May 24Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up
Mar 11Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital
Oct 23We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Jul 17Returns Are Gaining Momentum At Endymed (TLV:ENDY)
Apr 03Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher
Nov 18We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Jun 03Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price
Feb 13Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching
Nov 28Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital
Oct 31Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?
Aug 29Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist
Aug 01We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Apr 11Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Feb 15Returns On Capital - An Important Metric For Endymed (TLV:ENDY)
Jan 10Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?
Dec 14
Revenue & Expenses Breakdown
How Endymed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 19 | -2 | 8 | 3 |
| 30 Jun 24 | 20 | -1 | 8 | 3 |
| 31 Mar 24 | 21 | 0 | 8 | 3 |
| 31 Dec 23 | 23 | 1 | 8 | 3 |
| 30 Sep 23 | 23 | 1 | 7 | 3 |
| 30 Jun 23 | 22 | 1 | 7 | 3 |
| 31 Mar 23 | 22 | 1 | 6 | 3 |
| 31 Dec 22 | 21 | 1 | 6 | 3 |
| 30 Sep 22 | 22 | 3 | 5 | 3 |
| 30 Jun 22 | 23 | 4 | 5 | 3 |
| 31 Mar 22 | 24 | 5 | 5 | 3 |
| 31 Dec 21 | 22 | 5 | 5 | 3 |
| 30 Sep 21 | 20 | 2 | 5 | 2 |
| 30 Jun 21 | 19 | 2 | 6 | 2 |
| 31 Mar 21 | 16 | 1 | 5 | 2 |
| 31 Dec 20 | 14 | 0 | 5 | 2 |
| 30 Sep 20 | 14 | 1 | 5 | 2 |
| 30 Jun 20 | 14 | 1 | 5 | 2 |
| 31 Mar 20 | 15 | 2 | 5 | 2 |
| 31 Dec 19 | 16 | 2 | 6 | 2 |
| 30 Sep 19 | 18 | 2 | 6 | 2 |
| 30 Jun 19 | 18 | 2 | 6 | 2 |
| 31 Mar 19 | 18 | 2 | 6 | 2 |
| 31 Dec 18 | 18 | 2 | 6 | 2 |
| 30 Sep 18 | 18 | 0 | 7 | 2 |
| 30 Jun 18 | 19 | -1 | 7 | 2 |
| 31 Mar 18 | 18 | -1 | 7 | 2 |
| 31 Dec 17 | 18 | -3 | 8 | 2 |
| 30 Sep 17 | 18 | -3 | 8 | 3 |
| 30 Jun 17 | 17 | -2 | 7 | 3 |
| 31 Mar 17 | 15 | -3 | 7 | 3 |
| 31 Dec 16 | 14 | -3 | 7 | 4 |
| 30 Sep 16 | 13 | -4 | 6 | 4 |
| 30 Jun 16 | 12 | -5 | 6 | 4 |
| 31 Mar 16 | 13 | -4 | 6 | 4 |
| 31 Dec 15 | 13 | -4 | 6 | 3 |
| 30 Sep 15 | 13 | -2 | 6 | 3 |
| 30 Jun 15 | 13 | 0 | 6 | 3 |
| 31 Mar 15 | 12 | 0 | 5 | 2 |
| 31 Dec 14 | 11 | 0 | 4 | 2 |
| 30 Sep 14 | 8 | 0 | 3 | 2 |
| 30 Jun 14 | 7 | -1 | 3 | 2 |
| 31 Mar 14 | 7 | -1 | 2 | 2 |
| 31 Dec 13 | 6 | 0 | 2 | 2 |
Quality Earnings: ENDY is currently unprofitable.
Growing Profit Margin: ENDY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ENDY is unprofitable, and losses have increased over the past 5 years at a rate of 24.5% per year.
Accelerating Growth: Unable to compare ENDY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ENDY is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.1%).
Return on Equity
High ROE: ENDY has a negative Return on Equity (-13.73%), as it is currently unprofitable.